Amgen Faces Suit, Subpoenas Over Alleged Tying

Law360, New York (November 12, 2007, 12:00 AM EST) -- A health fund has filed a proposed class action lawsuit against biotech company Amgen Inc., alleging it is illegally tying and pricing the sales of three of its oncology products.

The lawsuit, filed Nov. 2 in the U.S. District Court for the District of New Jersey, was announced on Friday by Amgen in a filing with the U.S. Securities and Exchange Commission. The California-based company also disclosed that it had been subpoenaed by the U.S. Attorney's Offices of the Eastern District of New York and the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.